Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study

Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study

Gianenrico Senna,1,2 Maria Aliani,3 Elena Altieri,4 Pietro Bracciale,5 Luisa Brussino,6 Maria Filomena Caiaffa,7 Paolo Cameli,8 Giorgio Walter Canonica,9,10 Cristiano Caruso,11 Maria D’Amato,12 Fausto De Michele,13 Stefano Del Giacco,14 Fabiano Di Marco,15 Francesco Menzella,16 Girolamo Pelaia,17 Pa...

Full description

Bibliographic Details
Main Authors: Senna G, Aliani M, Altieri E, Bracciale P, Brussino L, Caiaffa MF, Cameli P, Canonica GW, Caruso C, D'Amato M, De Michele F, Del Giacco S, Di Marco F, Menzella F, Pelaia G, Rogliani P, Romagnoli M, Schino P, Schroeder JW, Vultaggio A, Rizzoli S, Zullo A, Boarino S, Palmisano M, Rossi A, Vitiello G, Centanni S
Format: Article
Language:English
Published: Dove Medical Press 2022-11-01
Series:Journal of Asthma and Allergy
Subjects:
severe eosinophilic asthma
blood eosinophil count
benralizumab
observational
real-world evidence
real-life
Online Access:https://www.dovepress.com/clinical-features-and-efficacy-of-benralizumab-in-patients-with-blood--peer-reviewed-fulltext-article-JAA

Internet

https://www.dovepress.com/clinical-features-and-efficacy-of-benralizumab-in-patients-with-blood--peer-reviewed-fulltext-article-JAA

Similar Items